Nationwide Case Review
Call 24/7 1-800-883-9858

  • Drugs Recalls
  • Devices and Implants
  • FDA Alerts
  • About Us
  • Español
  • Contact Us
Nationwide Case Review
Call 24/7 1-800-883-9858

  • Drugs Recalls
  • Devices and Implants
  • FDA Alerts
  • About Us
  • Español
  • Contact Us
Nationwide Case Review
Call 24/7 1-800-883-9858

  • Drugs Recalls
  • Devices and Implants
  • FDA Alerts
  • About Us
  • Español
  • Contact Us

FDA Dilantin Investigation

  • Home
  • FDA Reports FDA Alerts
  • FDA Dilantin Investigation
Published by on November 11, 2008
Categories
  • FDA Alerts
Tags

Agency Investigating Dilantin Risks of SJS and TEN

FDA is investigating new preliminary data regarding a potential increased risk of serious skin reactions including Stevens Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) from phenytoin therapy in Asian patients positive for human leukocyte antigen (HLA) allele, HLA-B*1502. This allele occurs almost exclusively in patients with ancestry across broad areas of Asia, including Han Chinese, Filipinos, Malaysians, South Asian Indians, and Thais. Until the FDA evaluation is completed, healthcare providers who are considering the use of phenytoin or fosphenytoin should be aware of the risks and benefits described in the current prescribing information for this drug. Healthcare providers should consider avoiding phenytoin and fosphenytoin as alternatives for carbamazepine in patients who test positive for HLA-B*1502. A summary of the data currently being analyzed by FDA, and information for patients and healthcare professionals to consider, can be found on the FDA’s website.

SOURCE: U.S. Food and Drug Administration (FDA)

Dilantin lawsuit information: Dilantin Lawsuits

Dilantin SJS information: Dilantin Stevens Johnson Syndrome Lawsuits

Dilantin TEN information: Dilantin Toxic Epidermal Necrolysis Lawsuits

See also: Dilantin Side Effects.

Speak to a Dilantin Lawyer

If you took Dilantin and suffered Stevens Johnson Syndrome (SJS) or Toxic Epidermal Necrolysis (TEN), we encourage you to contact a Dilantin attorney at our law firm immediately. An experienced product liability attorney can assist you in a legal action against the makers of Dilantin. Contact our law firm and learn more about your legal rights and the options available to you and your family.

Share

Review My Case

Free & Confidential Consultation

    board-certified-lawyer

    Attorney David P. Willis is a nationally recognized Trial Lawyer with more than 37 years of fighting for his clients' rights. Mr. Willis is a former Briefing Attorney for the Supreme Court of Texas and he is Board Certified in Personal Injury Trial Law since 1988.

    attorney-david-willis

    "Through his many years of dedication and service to his clients, David Willis has been successful in forcing many billion dollar corporations to make major safety changes to their products and the ways they conduct business."

    Willis-Law-Firm-awards
    Willis-Law-Firm-awards

    willis logo white

    Principle Office Location
    5005 Riverway Drive
    Suite 160
    Houston, TX 77056
    Call 24/7 1-800-883-9858

    THIS IS ATTORNEY ADVERTISING

    Contact Us Español About Us Notices & Disclaimer Privacy Policy

    © 2006-2020 Willis Law Firm. All Rights Reserved. Sitemap